CUJ has submitted the following questionnaire to the Minister of Health, Labour and Welfare, Mr. Katsunobu Kato.
On 31 July 2020, your ministry announced that it had reached a basic agreement with Pfizer Inc. of the United States to supply 60 million people with a new coronavirus vaccine by June of next year, if the vaccine is successful. Your ministry also announced on 7 August that it had reached an agreement in principle with AstraZeneca of the United Kingdom to receive 120 million doses of the vaccine, if successful, by early next year. Developed countries are working to secure the vaccine, and your ministry is actively working to secure it. This is a major agreement at a time when vaccines are not yet available and their effectiveness and safety are not even known.
Vaccines are causing health problems, especially among children, due to adverse reactions. Vaccines, unlike drugs, are administered to healthy people. We must be cautious as well as careful. In order to hasten the development of this new biotech vaccine, they are being developed in a different way than the traditional method of development, and the way the vaccine works is completely different. Moreover, large-scale vaccination is being considered. We can’t help but be very concerned about the damage caused by adverse reactions. For this reason, we would like to ask the following questions: